These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35933070)

  • 1. Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab".
    Cohen JM; Damsky W; Girardi M
    J Am Acad Dermatol; 2022 Dec; 87(6):e241-e242. PubMed ID: 35933070
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review.
    Jfri A; Smith JS; Larocca C
    J Am Acad Dermatol; 2023 May; 88(5):1164-1166. PubMed ID: 36481378
    [No Abstract]   [Full Text] [Related]  

  • 3. Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.
    Joshi TP; Duvic M
    J Am Acad Dermatol; 2023 Jun; 88(6):e305-e306. PubMed ID: 36858155
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab.
    Bai H; Murase EM; Ashbaugh AG; Botto NB; Murase JE
    J Am Acad Dermatol; 2022 Sep; 87(3):692-695. PubMed ID: 35367296
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous T-cell lymphoma and atopy: is there an association?
    Mehrany K; El-Azhary RA; Bouwhuis SA; Pittelkow MR
    Br J Dermatol; 2003 Nov; 149(5):1013-7. PubMed ID: 14632807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.
    Lazaridou I; Ram-Wolff C; Bouaziz JD; Bégon E; Battistella M; Rivet J; Jachiet M; Bagot M; de Masson A
    Acta Derm Venereol; 2020 Sep; 100(16):adv00271. PubMed ID: 32556342
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
    Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patch tests in Sézary syndrome and mycosis fungoides.
    Shupp DL; Winkelmann RK
    Contact Dermatitis; 1985 Sep; 13(3):180-5. PubMed ID: 4053598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
    Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
    Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.
    Shono Y; Suga H; Kamijo H; Fujii H; Oka T; Miyagaki T; Shishido-Takahashi N; Sugaya M; Sato S
    Acta Derm Venereol; 2019 Jul; 99(9):809-812. PubMed ID: 31045236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
    Sentis HJ; Willemze R; Scheffer E
    J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eczema and its treatment in older adults].
    Harries L; Traidl S; Klespe KC; Werfel T
    Dermatologie (Heidelb); 2023 Sep; 74(9):678-686. PubMed ID: 37638989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides.
    Fujimura T; Okuyama R; Ito Y; Aiba S
    Br J Dermatol; 2008 Jun; 158(6):1256-63. PubMed ID: 18363755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.
    Pulitzer MP; Horna P; Almeida J
    Cytometry B Clin Cytom; 2021 Mar; 100(2):132-138. PubMed ID: 32516521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
    Hoppe RT; Wood GS; Abel EA
    Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
    Rupniewska ZM
    Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
    Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
    An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
    Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
    Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.